Dr. Nisar Ul Khaliq (PhD KU, Korea)



Dr. Khaliq completed the Ph.D. degree in Pharmacy (nanomedicine/nano targeting drug delivery systems) under Sejong Foreign Scholarship Program from the College of Pharmacy, Korea University, South Korea in 2017. He worked as a multiple postdoc research associate at Korea University (S.K), T-gel Bio (S.K), Asan Medical School (S.K) and College of Pharmacy, Purdue University, (U.S.A). Dr. Khaliq has broad research interests in the areas of pharmaceutical science and pharmaceutical technology. His specific field of research focuses on nanomedicine/nano targeted drug delivery systems for diagnosis, therapy, theranostics and immunotherapy in cancer as well as other diseases. He has supervised and co-supervised post-graduate research projects. He is a member of American Association for the Advancement of Science (AAAS) and reviewer of International Journal of Pharmaceutics and Journal of Drug Delivery Science and Technology.

PhD Pharmacy (Drug Delivery System) Department of Physical Pharmacy / Drug Delivery System, College of Pharmacy, Korea University, South Korea 2017
MS Medical Biosciences in Medical Biology Department of Medical and Health Sciences (IMH), Linkoping University, Sweden 2012
Pharm.D. Pharmaceutical Sciences Department of Pharmacy Peshawar University, Pakistan 2008
Assistant Professor Capital University of Science and Technology (CUST), Islamabad Since – 2021
Member American Association for the Advancement of Science (AAAS), USA.
1. Sejong Foreign Student Scholarship for Ph.D. studies.
2. Best Work Award on Nanotheranostic Approach in 2012 for Young Researcher Category at Seminar on Nanoscience and Nanotechnology, Linköping University Sweden.
3. Appreciation Research Work by the Faculty Members of Pharmacy, Korea University for the Publication in Biomaterials (2016).
  1. Phase transition-induced nanoparticles for drug delivery;
  2. Chemotherapy;
  3. Sustained Release of Protein-based drug;
  4. Intelligent drug delivery system;
  5. In-situ sol-gel transition for targeted systems;
  6. Nanomedicine for diagnosis and therapy;
  7. Biomaterials and immunotherapy.
1. MS Caspase-activated doxorubicin-prodrug chemotherapy using nanoparticles
2. MS Efficacy of chemotherapy using drugs loaded nanoparticles to increase the immune response to treat metastasis
3. MS Exosomes loaded nanoparticle system for targeted chemotherapy
1. N.U. Khaliq, D. Chobisa, C.A. Richard, M.R. Swinney, and Y. Yeo, “Engineering microenvironment of biodegradable polyester systems for drug stability and release control,” Therapeutic Delivery, vol. 12, no. 1, pp. 37-54, 2021.
2. L. Khan, N.U. Khaliq, A. Ullah, N. Rafiq, and M. Ullah, “COVID-19 pandemic: Mechanistic approaches and gender vulnerabilities,” Saudi Pharmaceutical Journal, vol. 28, no. 12, pp. 1874-1876, 2020.
3. F. Sandra, N.U. Khaliq, A. Sunna, and A. Care, “Developing protein-based nanoparticles as versatile delivery systems for cancer therapy and imaging,” Nanomaterials, vol. 9, no. 9, pp. 1329, 2019.
4. M.T. Haseeb, N.U. Khaliq, S.H. Yuk, M.A. Hussain, and S. Bashir, “Linseed polysaccharides based nanoparticles for controlled delivery of docetaxel: design, in vitro drug release and cellular uptake,” Journal of Drug Delivery Science and Technology, vol. 49, pp. 143-151, 2019.
5. N.U. Khaliq, D.Y. Park, B.M. Yun, Y.W. Jung, J.H. Seo, C.S. Hwang, and S.H. Yuk, “Pluronics: Intelligent building units for targeted cancer therapy and molecular imaging,” International Journal of Pharmaceutics, vol. 556, pp. 30-44, 2019
6. N.U. Khaliq, D.Y. Park, H.J. Lee, K.S. Oh, J.H. Seo, S.Y. Kim, C.S. Hwang, T.-H. Lim, and S.H. Yuk, “Pluronic/Heparin Nanoparticles for Chemo-Photodynamic Combination Cancer Therapy through Photoinduced Caspase-3 Activation,” ACS Applied Nano Materials, vol. 1, no. 6, pp. 2943-2952, 2018
7. D. Baatar, M.Z. Siddiqi, W.T. Im, N. Ul Khaliq, and S.G. Hwang, “Anti-inflammatory effect of ginsenoside Rh2-mix on lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells,” Journal of Medicinal Food, vol. 21, no. 10, pp. 951-960, 2018
8. N.U. Khaliq, K.S. Oh, F.C. Sandra, Y. Joo, J. Lee, Y. Byun, I.-S. Kim, I.C. Kwon, J.H. Seo, and S.Y. Kim, “Assembly of polymer micelles through the sol-gel transition for effective cancer therapy,” Journal of Controlled Release, vol. 255, pp. 258-269, 2017
9. N.U. Khaliq, D.Y. Park, J.Y. Lee, Y. Joo, K.S. Oh, J.S. Kim, J.-S. Kim, I.-S. Kim, I.C. Kwon, and S.H. Yuk, “The multilayer nanoparticles for deep penetration of docetaxel into tumor parenchyma to overcome tumor microenvironment,” Colloids and Surfaces B: Biointerfaces, vol. 146, pp. 833-840, 2016.
10. N.U. Khaliq, F.C. Sandra, D.Y. Park, J.Y. Lee, K.S. Oh, D. Kim, Y. Byun, I.-S. Kim, I.C. Kwon, and S.Y. Kim, “Doxorubicin/heparin composite nanoparticles for caspase-activated prodrug chemotherapy,” Biomaterials, vol. 101, pp. 131-142, 2016.
11. H.K. Patra, N.U. Khaliq, T. Romu, E. Wiechec, M. Borga, A.P. Turner, and A. Tiwari, “MRI‐Visual Order–Disorder Micellar Nanostructures for Smart Cancer Theranostics,” Advanced Healthcare Materials, vol. 3, no. 4, pp. 526-535, 2014.

Other Members